Abstract
Alzheimer’s disease (AD) is the most common form of dementia, with no cure to stop its progression. Early detection, diagnosis, and intervention have become the hot spots in AD research. The long asymptomatic and slightly symptomatic phases of autosomal dominant AD (ADAD) allow studies to explore early biomarkers and the underlying pathophysiological changes. Functional magnetic resonance imaging (fMRI) provides a method to detect abnormal patterns of brain activity and functional connectivity in vivo, which correlates with cognitive decline earlier than structural changes and more strongly than amyloid deposition. Here, we will provide a brief overview of the network-level findings in ADAD in fMRI studies. In general, abnormalities in brain activity were mainly found in the hippocampus, the medial temporal lobe (MTL), the posterior cortex, the cingulate cortices, and the frontal regions in ADAD. Moreover, ADAD and sporadic AD (SAD) have similar fMRI changes, but not with aging.
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the progressive loss of cognitive function and independence, with extracellular plaque deposits of the β-amyloid peptide (Aβ) and flame-shaped neurofibrillary tangles of the microtubule-binding protein tau. Autosomal dominant AD (ADAD) accounts for less than 1% of all AD cases (), which is attributed to mutations in three genes: amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). Mutation carriers usually develop dementia at an early age (about 30 to 50 years of age), while sporadic AD (SAD) subjects develop symptoms of progressive amnesia and other cortical cognitive symptoms, usually after age 60. With mutation-specific exceptions and an earlier age of onset, ADAD is similar to SAD. Owing to the nearly 100% penetrance of ADAD, it is possible to identify early biomarkers and explore the initial pathophysiological mechanisms in cognitively unimpaired ADAD mutation carriers. Furthermore, studies that recruit subjects in pre-senile, mild-adulthood, or even childhood can reduce the impact of aging and other comorbidities on the results of functional magnetic resonance imaging (fMRI) research.
Functional magnetic resonance imaging is a technique for measuring and mapping brain activity and functional connectivity. It can be conducted in the resting state (rs-fMRI) or during the performance of particular cognitive tasks (task-related fMRI), which allows the assessment of intrinsic activity and polysynaptic connections in the brain. Task-based and resting-state represent the two most common experimental paradigms of functional neuroimaging. Task-related fMRI is model-driven and rs-fMRI analysis is data-driven. They can reflect different features of functional changes in the brain. By comparing the differences in the activation areas of different groups on the task, topics such as disease, development, and cognition can be analyzed. The rs-fMRI analysis is data-driven, and its analytical approach focuses on describing the synergistic and spontaneous activity of the brain. Blood oxygenation level-dependent (BOLD) imaging is the standard technique used to generate images in fMRI studies and relies on regional differences in cerebral blood flow to delineate regional activity. Functional connectivity matrices and hub nodes (central positions of brain information transmission) are typically used for fMRI data analysis. Growing evidence suggests that spontaneous activity of interregional neural synchrony has a coherent structure and may play a role in a host of cognitive and neural processes. Brain functional changes may accompany or even precede detectable structural alterations (; ), and brain activity and functional connectivity are more consistent with cognitive function than structural imaging and amyloid deposition (; ). Thus, exploring the functional changes in ADAD is useful for identifying early biomarkers and potential circuit-based therapeutic targets. fMRI studies have been widely demonstrated in aging (; ), late-onset AD (LOAD) (; ), and many other neurodegenerative disorders (), whereas ADAD-related fMRI studies are relatively insufficient. We will review brain functional changes and potential targets in ADAD based on task-related and resting-state fMRI studies. We systematically searched studies from MEDLINE (The National Library of Medicine), Web of Science, EMBASE, and Cochrane Library inception through 31 December 2021. The characteristics of studies investigating fMRI changes in ADAD are briefly summarized in Table 1.
TABLE 1
| Category | References | Mutated genes involved | Subjects | Ages of mutation carriers (years) | Cognition status of participants | fMRI tasks used/methods of functional connectivity analysis | Mainly affected brain regions | Publication year |
| Task-related neural networks | Mondadori C. R. A. THER et al. () | PSEN1 C410Y | N = 1 | 20 | preclinical stage | face-profession for episodic memory and working memory | enhanced brain activity in left frontal, temporal, and parietal neocortices during learning, retrieval, and novelty detection | 2006 |
| Mondadori C.R.A. et al. () | PSEN1 C410Y | N = 1 | 45 | aMCI | face-profession for episodic memory and working memory | significantly weaker MTL activity as well as many areas of weaker neocortical activity | 2006 | |
| Quiroz Y.T. et al. () | PSEN1 E280A | N (mutation carriers) = 20; N (mutation non-carriers) = 19 | Mean age ± SD = 33.70 ± 6.01 | preclinical stage | face-name paired-associate learning task | Increased activation of the right anterior hippocampus during encoding of novel face-name associations | 2010 | |
| Ringman J.M. et al. () | PSEN1 A431E, PSEN1 L235V, APP V717I | N (mutation carriers) = 11; N (mutation non-carriers) = 7 | Mean age (range): 29.9 (23 to 43) | preclinical stage | novelty encoding task | decreased BOLD signal in the anterior cingulate gyrus bilaterally and the left frontal pole during a novelty encoding task | 2011 | |
| Reiman E.M. et al. () | PSEN1 E280A | N (mutation carriers) = 20; N (mutation non-carriers) = 24 | Mean age ± SD = 22 ± 3 | preclinical stage | face-name associative memory encoding and novel viewing and control tasks | significantly greater activation in hippocampal and parahippocampal regions and less deactivation in precuneus and posterior cingulate regions | 2012 | |
| Braskie M. N. et al. () | PSEN1 A431E, PSEN1 L235V, APP V717I | N (mutation carriers) = 18; N (mutation non-carriers) = 8 | Mean age (range): 30.9 (19 to 43) | preclinical period to MCI stage | novelty encoding task | no significant difference in fMRI activity between mutation carriers and non-carriers; greater fMRI activity in the fusiform and middle temporal gyri when approaching the familial age of disease diagnosis | 2012 | |
| Braskie M. N. et al. () | PSEN1 A431E, PSEN1 L235V, APP V717I | N (mutation carriers) = 9; N (mutation non-carriers) = 8 | Mean age ± SD = 29.8 ± 5.6 | preclinical stage | verbal paired associates task | less fMRI activity in the left hippocampus during memory retrieval | 2013 | |
| Sala-Llonch R. et al. () | PSEN1 mutations (M139T, K239N, L235R, L282R, L286P, I439S) | N (mutation carriers) = 19; N (mutation non-carriers) = 13 | AMC: Mean age ± SD = 39.09 ± 10.74; SMC: Mean age ± SD = 48.91 ± 7.53 | preclinical period to dementia stage | visual encoding task | SMC showed reduced activity in regions of the left occipital and left prefrontal cortices, while both AMC and SMC showed increased activity in a region within the precuneus/posterior cingulate | 2013 | |
| Quiroz Y.T. et al. () | PSEN1 E280A | N (mutation carriers) = 18; N (mutation non-carriers) = 19 | Mean age ± SD = 13 ± 2 | preclinical stage | face-name associative encoding task | less fMRI deactivation of posterior parietal regions during a memory encoding task | 2015 | |
| Resting-state networks | Chhatwal J.F et al. () | PSEN1: 68, PSEN2: 5, APP: 10 | N (mutation carriers) = 83; N (mutation non-carriers) = 37 | AMC: Mean age ± SD = 34.64 ± 8.04; early SMC: Mean age ± SD = 44.46 ± 11.74; SMC with dementia: Mean age ± SD = 49.33 ± 9.72 | preclinical period to dementia stage | independent component analysis | significantly decreased DMN fcMRI in the precuneus/posterior cingulate and parietal cortices | 2013 |
| Sala-Llonch R. et al. () | PSEN1 mutations (M139T, K239N, L235R, L282R, L286P, I439S) | N (mutation carriers) = 19; N (mutation non-carriers) = 13 | AMC: Mean age ± SD = 39.09 ± 10.74; SMC: Mean age ± SD = 48.91 ± 7.53 | preclinical period to dementia stage | seed-based correlation analysis | increased frontal connectivity and reduced posterior connectivity in AMC and decreased frontal and increased posterior connectivity in SMC | 2013 | |
| Thomas J.B. et al. () | mutations not identified in the text | N (mutation carriers) = 54; N (mutation non- carriers) = 25 | CDR = 0: Mean age ± SD = 33.9 ± 8.5; CDR = 0.5: Mean age ± SD = 41.4 ± 10.4; CDR ≥ 1: Mean age ± SD = 49.4 ± 8.7 | preclinical period to MCI stage | seed-based correlation analysis | lower functional connectivity in multiple resting-state networks in asymptomatic mutation carriers near anticipated age of symptom onset; largely similar functional connectivity changes owing to advanced AD in LOAD and ADAD | 2014 | |
| Quiroz Y.T. et al. () | PSEN1 E280A | N (mutation carriers) = 18; N (mutation non-carriers) = 19 | Mean age ± SD = 13 ± 2 | preclinical period | seed-based correlation analysis | no differences in functional connectivity in the whole network metric | 2015 | |
| Zhao T. et al. () | PSEN1: 16, PSEN2: 1, APP: 9 | N (mutation carriers) = 26; N (mutation non-carriers) = 29 | Mean age ± SD = 33.65 ± 4.43 | preclinical period | seed-based correlation analysis | decreased connectivity of left precuneus with right precuneus and superior frontal gyrus and decreased connectivity of medial frontal gyrus with middle frontal gyrus | 2020 | |
| Quan M. et al. () | PSEN1 mutations (H163R, L282V, L392V, M270L, L271V, M139V, M139L, I213T, A285V, F105I, I100F, K311R, P433S, G111V, L173F, G206S), PSEN2 (F181I, V214L, M298T, G34S), and APP (I716T, V717I, V715M) | N (mutation carriers) = 70; N (mutation non-carriers) = 102 | AMC: Mean age ± SD = 36.3 ± 15.7; SMC: Mean age ± SD = 50.5 ± 9.4 | preclinical period to dementia stage | seed-based correlation analysis | increased diffusivity of the left hippocampus-PCC circuit in presymptomatic mutation carriers; impaired caudate-rMFG and putamen rMFG circuits in APP gene mutation carriers; increased fiber numbers of putamen-rMFG circuit in PSEN1 gene mutation carriers. | 2020 | |
| Ewers M. et al. () | PSEN1, PSEN2, APP | N (mutation carriers) = 108; N (mutation non-carriers) = 71 | Mean age ± SD = 38.0 ± 10.5 | preclinical period to dementia stage | seed-based correlation analysis | higher fMRI-assessed system segregation to be associated with an attenuated effect of estimated years from symptom onset on global cognition | 2021 |
Characteristics of studies investigating functional magnetic resonance imaging (fMRI) changes in autosomal dominant Alzheimer’s disease (ADAD).
ADAD, autosomal dominant Alzheimer’s disease; PSEN, presenilin; APP, amyloid precursor protein; CDR, clinical dementia rating; aMCI, amnestic mild cognitive impairment; AMC, asymptomatic mutation carrier; SMC, symptomatic mutation carrier; MTL, medial temporal lobe; rMFG, rostral middle frontal gyrus; DMN, default mode network; BOLD, blood oxygen level dependent.
Task-Related Neural Networks in Autosomal Dominant Alzheimer’s Disease
Task-related fMRI can be used to study brain activity when a subject is engaged in a given task. Loss of memory, an early and prominent symptom in patients with AD, correlates with parameters of structural or functional brain integrity. Memory tasks are the most widely used in ADAD fMRI studies. The selection of specific neural networks and abnormalities found in fMRI studies depend heavily on the types of memory or behavior tasks engaged. Despite this, the medial temporal lobe (MTL) (; , ; , ; ) has been demonstrated to be selectively impaired in ADAD along with the posterior cingulate cortex (PCC) (; ) which are also regions of early structural and F-18 2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) biomarkers in ADAD.
A pioneering fMRI study on ADAD related to memory tasks reported only two mutation carriers (PSEN1 C410Y) (). The 20-year-old mutation carrier displayed enhanced brain activity in the left frontal, the temporal, and the parietal neocortices, while activity levels of the 45-year-old mutation carrier were generally low in many left and right hippocampal segments during episodic memory tasks, but not working memory. Increased activity in the middle temporal gyri and the fusiform was also demonstrated during the novelty encoding tasks in other research, as the subjects approached the estimated age of onset (). The estimated age of onset means that people who carry a familial Alzheimer’s gene tend to develop symptoms at around the same age. This helps researchers predict their disease stage and select participants for clinical trials. Increased activity may be partially explained by neuro hypertrophy, neuroinflammation, and fiber sprouting during the compensatory stage of pathophysiology (; ; ; ). These studies suggest that increased fMRI activity in the temporal lobe may be related to incipient ADAD processes, and episodic memory tasks may potentially be manageable to provoke brain activity in the pre-clinical phase of AD (the stage occurring before a clinical diagnosis of a cognitive disorder). The studies have also shown decreased activity of the temporal region in cognitively unimpaired ADAD mutation carriers. In the verbal paired-associate task fMRI study, pre-symptomatic mutation carriers showed less fMRI activity in the hippocampus and the posterior middle temporal gyrus than controls during retrieval (). This may be due to the different tasks or the older age of the participants in the latter study. Overall, the hippocampus, the middle temporal gyri, the fusiform, and the middle temporal gyri presented early activity changes in fMRI in subjects at risk for ADAD. It has been reported that the hippocampus can interact with the fusiform gyrus to participate in cognitive networks. Activation in the hippocampus may be related to the novelty of the stimulus, while the fusiform gyrus has been proven to be important in novelty encoding (), object processing (), and recognition of complex visual stimuli ().
As for the PCC and parietal region, asymptomatic mutation carriers showed increased BOLD activity in the posterior cingulate and symptomatic mutations carriers showed increased activity in the lingual gyrus, with precuneus cortex activity increased in both the asymptomatic and symptomatic mutation carriers during the visual memory encoding task, compared to non-mutation carriers (). In a verbal paired-associate task-related fMRI study, less signal in the inferior parietal cortex and the precuneus during retrieval, not encoding, was found in pre-symptomatic mutation carriers. Even after controlling for gray matter volume as a covariate, there were still significant differences in these regions, which indicated that atrophy could not explain the entire effect (). The PCC, precuneus, and parietal cortex are involved in many cognitive functions, including episodic memory, working memory, the focus of attention, visuospatial processing, etc. The involvement of the precuneus/PCC is significant in the development of ADAD. Early amyloid deposition, abnormal structure, and reduced metabolism in these regions have been observed in ADAD (; ; ; ). Changes in the PCC and parietal cortex in task-related fMRI in asymptomatic subjects at risk for ADAD further suggest that the posterior cortical regions play key roles in the development of dementia.
The anterior cingulate gyrus and frontal lobes are also vulnerable regions in the functional imaging studies of ADAD. During the novelty encoding trials (), decreased BOLD signals in the anterior cingulate gyrus bilaterally and the left frontal pole were found in pre-symptomatic mutation carriers, compared with matching cognitively normal family members. In addition, decreased BOLD activity in regions of the left middle and inferior frontal gyri, the left frontal operculum, and the left lateral occipital cortex was also found in symptomatic mutation carriers during the visual memory encoding task (). The anterior cingulate correlates with the striatum via frontal-subcortical circuits (), and abnormal frontostriatal connectivity in both APP and PSEN1 mutation carriers and its association with general cognitive function were also reported by Quan et al. using rs-fMRI. The anterior cingulate and frontal regions are involved in certain higher-level functions, such as attention allocation, decision-making, emotion, and memory. The anterior cingulate is also part of the salience network (), which might be selectively activated during the processing of novel stimuli. Decreased glucose metabolism and cerebral blood flow in the anterior cingulate in pre-symptomatic subjects carrying PSEN1 mutations (), abnormalities in functional connectivity in aging, and mild cognitive impairment have been described ().
A series of task-related fMRI studies were conducted in the big Colombian pedigree (PSEN1 E280A) to explore brain activity in children (9–17 years old) (), young adults (18–26 years old) (), and middle-aged adults (average age 33.7 years old) (), who were all younger than 44 years old (mean age at onset of the disease ()). The encoding and viewing of novel face-name pairs (associative memory functioning task) were employed among these subjects. The analysis focused on the hippocampal system in the middle-aged adult group. Compared to non-carriers, cognitively intact PSEN1 mutation-carrying adults demonstrated hyperactivation within the right anterior hippocampus during the encoding of novel associations. In young adults, mutation carriers showed significantly greater activation in the hippocampal and parahippocampal regions and less deactivation in the precuneus and posterior cingulate regions. Interactions remained significant in the right hippocampus, the right parahippocampal gyrus, the right precuneus, and the right posterior cingulate regions, after correction for multiple comparisons. Compared to non-carriers, mutation-carrying children appeared to have less deactivation in the posterior parietal regions. However, there were no significant differences between the groups in MTL activation, either when controlling for age or when looking at age-related slopes. In summary, compared to non-carriers, PSEN1 E280A mutation carriers showed less deactivation in the precuneus and posterior cingulate regions during teenager and young adulthood, while the increased activity of the hippocampal and parahippocampal regions began from early adulthood and lasted until middle adulthood during memory association tasks.
In general, abnormalities in brain activity were found in the hippocampus, the MTL, the posterior cortex, the anterior and posterior cingulate cortices, and the middle and inferior frontal regions. These regions are also critical for cognitive function and show structural and pathological changes during the early phase of ADAD. The results of different studies vary in the affected brain regions and changes in activity. Possible explanations for these inconsistent results may be due to discrepant tasks, different populations, subjects’ ages, and levels of cognition. Unified and standard task performance is needed in future studies when conducting meta-analyses.
Resting-State Networks in Autosomal Dominant Alzheimer’s Disease
Resting-state functional magnetic resonance imaging, which evaluates brain regional interactions during the resting condition, can be used to study patterns of intrinsic brain connectivity or functional work in vivo. rs-fMRI measures spontaneous low-frequency fluctuations in the BOLD signal to investigate the functional architecture of the brain and allows the identification of various resting-state networks, or spatially distinct areas of the brain that demonstrate synchronous BOLD fluctuations at rest. Neural networks in rs-fMRI include several components (), with the default mode network (DMN) being the most studied and easily visualized network (). The DMN involves the precuneus and PCC, the parietal and temporal cortices bilaterally, the medial prefrontal cortex (mPFC), and some regions within the hippocampal memory system. Exploring the changes in restating state networks in ADAD may provide non-invasive functional imaging biomarkers for early diagnosis and interventions in ADAD.
In a DMN study of children, who were much younger than the estimated age of onset, in the big Colombian pedigree (), no differences in functional connectivity in the whole network metric (six pre-defined nodes) were found. However, greater functional connectivity between the PCC and the bilateral MTL regions was found in mutation carriers than in non-carriers. No reduction in functional connectivity was observed in the mutation carriers. The opposite results were found in other studies using the independent component correlation algorithm (), in which functional connectivity within much of the DMN was decreased in ADAD mutation carriers compared with non-carriers. The most apparent decreased connectivity was with the major posterior node of the DMN (precuneus/posterior cingulate, PPC), along with the anterior node of the DMN (mPFC) and bilateral parietal cortices. Furthermore, compared with non-mutation carriers, functional connectivity in the PPC and right parietal cortex was decreased in asymptomatic mutation carriers, whereas decreased functional connectivity in the PPC, mPFC, and the left and right parietal cortices was observed in symptomatic mutation carriers. More complex and divergent results were reported by . The anterior components of the DMN were increased in asymptomatic subjects and decreased in symptomatic subjects, while the posterior components of the DMN were decreased in asymptomatic subjects and increased in symptomatic subjects, compared with controls. However, these studies also found that decreased functional connectivity within both the posterior and anterior DMN in the pre-symptomatic stage of ADAD, and connectivity disruption within the posterior DMN was disrupted earlier (). provided novel evidence of changes in neural circuits in ADAD using rs-fMRI, combined with T1 structural MRI and diffusion tensor imaging. The anterior resting networks and frontostriatal circuits were affected in the asymptomatic stage of ADAD. More narrowly, frontostriatal circuits were impaired and functional connectivity was decreased in APP mutation carriers, while the connectivity of the putamen-rostral middle frontal gyrus (putamen-rMFG) showed increases in PSEN1 mutation carriers. In summary, both anterior and posterior functional connectivity of the DMN can be affected in pre-symptomatic and symptomatic subjects, with the PCC, MTL regions, and pre-frontal cortex being more prominent. Meanwhile, altered functional connectivity in mutation carriers has been observed for several years or even over a decade before symptom onset (; ). Furthermore, a significant interaction between mutation carrier status and estimated years from symptom onset (EYO) with a significant negative correlation between fMRI and EYO in mutation carriers was also demonstrated, but not in non-carriers. Interestingly, less fMRI deactivation of the parietal regions in the absence of MTL alterations was also observed, which suggests that functional abnormalities in the parietal region may precede MTL changes early in the disease. A hypothesis has been raised that higher segregation of the functional networks represents a functional mechanism underlying cognitive resilience in AD, and higher fMRI-assessed system segregation was found to be associated with an attenuated effect of EYO on global cognition ().
Differences in resting-state networks were compared between ADAD and aging, and between ADAD and LOAD. In general, the degradation pattern of functional connectivity in ADAD was similar to that in LOAD (), but it was different from that in aging (). Inter- and intra-network functional connectivity decreases with increasing Clinical Dementia Rating (CDR) were similar for both ADAD and LOAD in multiple resting-state networks, including DMN. With some subtle differences observed, there was a modestly greater effect on disease severity seen in ADAD than in LOAD, which possibly reflected a faster spread of pathology across diseased connections in ADAD. As for ADAD versus aging, cognitive networks were preferentially degraded in ADAD, with changes in motor and visual networks seen only in the advanced stages. A contrasting degradation pattern was observed in aging subjects, where visual networks degraded to a similar or greater degree than cognitive networks. Both studies also demonstrated that inter-network connections were preferentially targeted in ADAD, with intra-network connections relatively spared. The results suggest that particular networks are selectively vulnerable in ADAD and support the ‘network diffusion’ models of AD progression (), which preferentially degrades connections within cognitive networks. This evidence supports that aging and AD demonstrate distinct pathophysiological mechanisms and that ADAD may serve as an effective model to study LOAD pathophysiology.
Conclusion and Perspectives
The hippocampus, the medial temporal region, the precuneus, the inferior parietal cortex, and the anterior and posterior cingulate cortices are key hubs in both task-related and rs-fMRI in ADAD. Inter- and intra-networks in these regions, along with the striatum, present abnormal functional connectivity in the early pre-symptomatic stages of ADAD, with the former being much more prominent. The regional brain activity and functional connectivity decrease as subjects carrying mutations approach the estimated age of onset or cognitive function gradually deteriorates.
As for neural reserves, most previous studies have been conducted in aging and SAD populations, while similar studies in ADAD are scarce. A recent study demonstrated that higher levels of global functional connectivity of the left frontal cortex were associated with attenuating effects of AD pathology on cognition in prodromal ADAD (mild cognitive impairment due to AD plus very mild AD dementia) (). It has been demonstrated that increased connectivity of frontal hubs is associated with cognitive training (), transcranial magnetic stimulation, transcranial direct-current stimulation (; ), or physical exercise (), and increased hub connectivity is associated with better cognition (; ). ADAD provides a good vehicle for conducting early and longitudinal neuroimaging studies or intervention studies to further elucidate how neural reserve and compensation evolve at different stages of ADAD and the relationship between cognitive reserve and its neural correlates. Exploring the mechanism under the neural network-level treatment helps to discover the potential molecular targets of ADAD, which helps in the development of drug therapy.
Considering that ADAD accounts for less than 1% of all AD cases, fMRI studies on ADAD are insufficient and the results are inconsistent. These findings are difficult to integrate due to different choices of subjects, tasks, regions of interest, etc. Moreover, cross-center effects are not yet widely recognized. ADAD is a subtype of rapidly progressive dementia with certain heterogeneity, and its fMRI characteristics require more detailed hierarchical analysis based on age, genotype, biomarkers, etc. is warranted. Future fMRI studies in ADAD are needed to optimize more specific connectivity composites, investigate the network-level neural underpinnings of cognitive alterations, and clarify the chronological order of fMRI changes and other pathophysiological biomarkers of ADAD progression. Using multi-network or inter-network composite connectivity measures may be particularly useful for increasing the specificity of functional connectivity MRI biomarkers and reducing the impact of common confounding conditions. Moreover, technical factors are critical in assessing fMRI: small amounts of head movement that are not easily detected and multiple different methods of data analysis can confound the results. Subsequent studies can compare different techniques to obtain sensitive and stable parameters and combinations of parameters and sites for detecting microstructural changes. Reliable multi-center studies will bring major progress in fMRI research on ADAD.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Funding
This study was supported by the Key Project of the National Natural Science Foundation of China (81530036); the National Key Scientific Instrument and Equipment Development Project (31627803); the Mission Program of Beijing Municipal Administration of Hospitals (SML20150801); the Beijing Scholars Program; the Beijing Brain Initiative from Beijing Municipal Science and Technology Commission (Z161100000216137); the Innovation Base Training and Development Special Program (Z171100002217007); the CHINA-CANADA Joint Initiative on Alzheimer’s Disease and Related Disorders (81261120571), and the Project for Outstanding Doctor with Combined Ability of Western and Chinese Medicine.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Acosta-BaenaN.Sepulveda-FallaD.Lopera-GómezC. M.Jaramillo-ElorzaM. C.MorenoS.Aguirre-AcevedoD. C.et al (2011). Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer’s disease: a retrospective cohort study.Lancet Neurol.10213–220. 10.1016/S1474-4422(10)70323-9
2
AnckaertsC.BlockxI.SummerP.MichaelJ.HamaideJ.KreutzerC.et al (2019). Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer’s Disease: A longitudinal MRI study.Neurobiol. Dis.12493–107. 10.1016/j.nbd.2018.11.010
3
BekrisL. M.YuC. E.BirdT. D.TsuangD. W. (2010). Review article: Genetics of Alzheimer disease.J. Geriatric Psychiatr. Neurol.23213–227.
4
BraskieM. N.MedinaL. D.Rodriguez-AgudeloY.GeschwindD. H.Macias-IslasM. A.CummingsJ. L.et al (2012). Increased fMRI signal with age in familial Alzheimer’s disease mutation carriers.Neurobiol. Aging33424.e11–21.
5
BraskieM. N.MedinaL. D.Rodriguez-AgudeloY.GeschwindD. H.Macias-IslasM. A.ThompsonP. M.et al (2013). Memory performance and fMRI signal in presymptomatic familial Alzheimer’s disease.Hum. Brain Mapp.343308–3319. 10.1002/hbm.22141
6
BucknerR. L. (2012). The serendipitous discovery of the brain’s default network [Internet]. Vol. 62, NeuroImage.Neuroimage621137–1145.
7
CeraN.EspositoR.CieriF.TartaroA. (2019). Altered Cingulate Cortex Functional Connectivity in Normal Aging and Mild Cognitive Impairment.Front. Neurosci.13:857. 10.3389/fnins.2019.00857
8
ChenA. C.OathesD. J.ChangC.BradleyT.ZhouZ. W.WilliamsaL. M.et al (2013). Causal interactions between fronto-parietal central executive and default-mode networks in humans.Proc. Natl. Acad. Sci. U.S.A.11019944–19949.
9
ChenJ. J. (2019). Functional MRI of brain physiology in aging and neurodegenerative diseases.Neuroimage187209–225.
10
ChhatwalJ. P.SchultzA. P.JohnsonK. A.HeddenT.JaimesS.BenzingerT. L. S.et al (2018). Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing.Brain1411486–1500.
11
ChhatwalJ. P.SchultzA. P.JohnsonK.BenzingerT. L. S.JackC.AncesB. M.et al (2013). Impaired default network functional connectivity in autosomal dominant Alzheimer disease.Neurology81736–744.
12
ColeM. W.YarkoniT.RepovšG.AnticevicA.BraverT. S. (2012). Global connectivity of prefrontal cortex predicts cognitive control and intelligence.J. Neurosci.328988–8999.
13
DickersonB. C.SperlingR. A. (2009). Large-scale functional brain network abnormalities in alzheimer’s disease: Insights from functional neuroimaging [Internet].Behav. Neurol.2163–75.
14
DuzelE.Van PraagH.SendtnerM. (2016). Can physical exercise in old age improve memory and hippocampal function?Brain139662–73.
15
EwersM.LuanY.FrontzkowskiL.NeitzelJ.RubinskiA.DichgansM.et al (2021). Segregation of functional networks is associated with cognitive resilience in Alzheimer’s disease.Brain1442176–2185. 10.1093/brain/awab112-2185
16
FranzmeierN.DüzelE.JessenF.BuergerK.LevinJ.DueringM.et al (2018). Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease.Brain1411186–1200. 10.1093/brain/awy008-1200
17
HashimotoM.MasliahE. (2004). Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer’s and Dementia with Lewy Bodies.Neurochem. Res.281743–1756. 10.1023/a:1026073324672
18
JannkKimH.AlbrechtD.WangD. (2020). fMRI complexity is associated with tau-PET and cognitive decline in Alzheimer’s disease.Alzheimer’s Dement16:e045411. 10.1002/alz.045411
19
JohnsonK. A.JonesK.HolmanB. L.BeckerJ. A.SpiersP. A.SatlinA.et al (1998). Preclinical prediction of Alzheimer’s disease using SPECT.Neurology501563–1571.
20
JohnsonK. A.LoperaF.JonesK.BeckerA.SperlingR.HilsonJ.et al (2001). Presenilin-1 – Associated abnormalities in regional cerebral perfusion.Neurology561545–1551. 10.1212/wnl.56.11.1545
21
KimK.EkstromA. D.TandonN. (2016). A network approach for modulating memory processes via direct and indirect brain stimulation: Toward a causal approach for the neural basis of memory.Neurobiol. Learn. Memory134162–177. 10.1016/j.nlm.2016.04.001
22
LiuJ.XiaM.DaiZ.WangX.LiaoX.BiY.et al (2017). Intrinsic Brain Hub Connectivity Underlies Individual Differences in Spatial Working Memory.Cereb. Cortex275496–5508. 10.1093/cercor/bhw317
23
MondadoriC. R. A.BuchmannA.MustovicH.SchmidtC. F.BoesigerP.NitschR. M.et al (2006). Enhanced brain activity may precede the diagnosis of Alzheimer’s disease by 30 years.Brain1292908–2922. 10.1093/brain/awl266
24
MoussaM. N.SteenM. R.LaurientiP. J.HayasakaS. (2012). Consistency of Network Modules in Resting-State fMRI Connectome Data.PLoS One7:e44428. 10.1371/journal.pone.0044428
25
NakamuraA.CuestaP.KatoT.ArahataY.IwataK.YamagishiM.et al (2017). Early functional network alterations in asymptomatic elders at risk for Alzheimer’s disease.Sci. Rep.7:6517. 10.1038/s41598-017-06876-8
26
QuanM.ZhaoT.TangY.LuoP.WangW.QinQ.et al (2020). Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease.Alzheimers Res. Ther.12:14. 10.1186/s13195-019-0572-2
27
QuirozY. T.BudsonA. E.CeloneK.RuizA.NewmarkR.CastrillónG.et al (2010). Hippocampal hyperactivation in presymptomatic familial Alzheimer’s disease.Ann. Neurol.68865–875. 10.1002/ana.22105
28
QuirozY. T.SchultzA. P.ChenK.ProtasH. D.BrickhouseM.FleisherA. S.et al (2015). Brain imaging and blood biomarker abnormalities in children with autosomal dominant Alzheimer disease a cross-sectional study.JAMA Neurol.72912–919. 10.1001/jamaneurol.2015.1099
29
QuirozY. T.SperlingR. A.NortonD. J.BaenaA.Arboleda-VelasquezJ. F.CosioD.et al (2018). Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.JAMA Neurol.75548–556.
30
RajA.LoCastroE.KuceyeskiA.TosunD.RelkinN.WeinerM. (2015). Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer’s Disease.Cell Rep.10359–369. 10.1016/j.celrep.2014.12.034
31
ReasE. T.HaglerD. J.KupermanJ. M.WierengaC. E.GalaskoD.WhiteN. S.et al (2020). Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.J. Alzheimers Dis.73347–357. 10.3233/JAD-190871
32
ReimanE. M.QuirozY. T.FleisherA. S.ChenK.Velez-PardoC.Jimenez-Del-RioM.et al (2012). Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer’s disease in the presenilin 1 E280A kindred: A case-control study.Lancet Neurol.111048–1056. 10.1016/S1474-4422(12)70228-4
33
RingmanJ. M.MedinaL. D.BraskieM.Rodriguez-AgudeloY.GeschwindD. H.MacIas-IslasM. A.et al (2011). Effects of risk genes on BOLD activation in presymptomatic carriers of familial alzheimer’s disease mutations during a novelty encoding task.Cereb. Cortex21877–83. 10.1093/cercor/bhq158
34
Sala-LlonchR.Bartrés-FazD.JunquéC. (2015). Reorganization of brain networks in aging: a review of functional connectivity studies.Front. Psychol.6:663. 10.3389/fpsyg.2015.00663
35
Sala-LlonchR.ForteaJ.Bartrés-FazD.BoschB.LladóA.Peña-GómezC.et al (2013). Evolving brain functional abnormalities in psen1 mutation carriers: A resting and visual encoding FMRI study.J. Alzheimer’s Dis.36165–175. 10.3233/JAD-130062
36
SanchezJ. S.HanseeuwB. J.LoperaF.SperlingR. A.BaenaA.BocanegraY.et al (2021). Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study.Alzheimers Res. Ther.13:27. 10.1186/s13195-020-00765-5
37
SeeleyW. W.MenonV.SchatzbergA. F.KellerJ.GloverG. H.KennaH.et al (2007). Dissociable intrinsic connectivity networks for salience processing and executive control.J. Neurosci.272349–2356.
38
SperlingR. A.DickersonB. C.PihlajamakiM.VanniniP.LaVioletteP. S.VitoloO. V.et al (2010). Functional alterations in memory networks in early Alzheimer’s disease.Neuromol. Med.1227–43.
39
SternC. E.CorkinS.GonzálezR. G.GuimaraesA. R.BakerJ. R.JenningsP. J.et al (1996). The hippocampal formation participates in novel picture encoding: Evidence from functional magnetic resonance imaging.Proc. Natl. Acad. Sci. U.S.A.938660–8665.
40
SternE. A.BacskaiB. J.HickeyG. A.AttenelloF. J.LombardoJ. A.HymanB. T. (2004). Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques.J. Neurosci. Off. J. Soc. Neurosci.244535–4540.
41
TakeuchiH.TakiY.NouchiR.SekiguchiA.KotozakiY.NakagawaS.et al (2017). Neural plasticity in amplitude of low frequency fluctuation, cortical hub construction, regional homogeneity resulting from working memory training.Sci. Rep.7:1470. 10.1038/s41598-017-01460-6
42
ThomasJ. B.BrierM. R.BatemanR. J.SnyderA. Z.BenzingerT. L.XiongC.et al (2014). Functional connectivity in autosomal dominant and late-onset Alzheimer disease.JAMA Neurol.711111–22.
43
TylerL. K.StamatakisE. A.BrightP.AcresK.AbdallahS.RoddJ. M.et al (2004). Processing objects at different levels of specificity.J. Cogn. Neurosci.16351–62.
44
VemuriP.JonesD. T.JackC. R. (2012). Resting state functional MRI in Alzheimer’s disease [Internet]. Vol. 4, Alzheimer’s Research and Therapy.Alzheimers Res. Ther.4:2.
45
YamaguchiS.HaleL. A.D’EspositoM.KnightR. T. (2004). Rapid prefrontal-hippocampal habituation to novel events.J. Neurosci.245356–5363. 10.1523/JNEUROSCI.4587-03.2004
46
YokoiT.WatanabeH.YamaguchiH.BagarinaoE.MasudaM.ImaiK.et al (2018). Involvement of the precuneus/posterior cingulate cortex is significant for the development of Alzheimer’s disease: A PET (THK5351, PiB) and resting fMRI study.Front. Aging Neurosci.10:304. 10.3389/fnagi.2018.00304
47
ZhaoT.QuanM.JiaJ. (2020). Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer’s Disease.J. Alzheimers Dis.731435–1444. 10.3233/JAD-191065
48
ZottB.BuscheM. A.SperlingR. A.KonnerthA. (2018). What Happens with the Circuit in Alzheimer’s Disease in Mice and Humans?Annu. Rev. Neurosci.41277–297.
Summary
Keywords
autosomal dominant Alzheimer’s disease, neural network, functional MRI (fMRI), presenilin, amyloid precursor protein (APP)
Citation
Qiu Q (2022) Neural Networks in Autosomal Dominant Alzheimer’s Disease: Insights From Functional Magnetic Resonance Imaging Studies. Front. Aging Neurosci. 14:903269. doi: 10.3389/fnagi.2022.903269
Received
14 April 2022
Accepted
03 June 2022
Published
19 July 2022
Volume
14 - 2022
Edited by
Ian M. McDonough, The University of Alabama, United States
Reviewed by
Joshua Thomas Fox-Fuller, Boston University, United States; Hwamee Oh, Brown University, United States
Updates
Copyright
© 2022 Qiu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qiongqiong Qiu, quntitled@126.com
This article was submitted to Neurocognitive Aging and Behavior, a section of the journal Frontiers in Aging Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.